- Home
- HCM vs DKL Comparison
HCM vs DKL Comparison
Compare HCM & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- DKL
- Stock Information
- Founded
- HCM 2000
- DKL 2012
- Country
- HCM Hong Kong
- DKL United States
- Employees
- HCM N/A
- DKL N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- DKL Natural Gas Distribution
- Sector
- HCM Health Care
- DKL Energy
- Exchange
- HCM Nasdaq
- DKL Nasdaq
- Market Cap
- HCM 2.3B
- DKL 2.3B
- IPO Year
- HCM N/A
- DKL N/A
- Fundamental
- Price
- HCM $13.52
- DKL $43.18
- Analyst Decision
- HCM Hold
- DKL Buy
- Analyst Count
- HCM 1
- DKL 4
- Target Price
- HCM $19.00
- DKL $44.25
- AVG Volume (30 Days)
- HCM 85.0K
- DKL 146.9K
- Earning Date
- HCM 02-26-2025
- DKL 02-25-2025
- Dividend Yield
- HCM N/A
- DKL 10.15%
- EPS Growth
- HCM N/A
- DKL N/A
- EPS
- HCM N/A
- DKL 2.83
- Revenue
- HCM $610,806,000.00
- DKL $984,922,000.00
- Revenue This Year
- HCM N/A
- DKL N/A
- Revenue Next Year
- HCM $18.76
- DKL $4.99
- P/E Ratio
- HCM N/A
- DKL $15.19
- Revenue Growth
- HCM N/A
- DKL N/A
- 52 Week Low
- HCM $13.00
- DKL $37.02
- 52 Week High
- HCM $21.92
- DKL $46.50
- Technical
- Relative Strength Index (RSI)
- HCM 40.71
- DKL 51.64
- Support Level
- HCM $13.10
- DKL $42.89
- Resistance Level
- HCM $13.92
- DKL $44.33
- Average True Range (ATR)
- HCM 0.38
- DKL 1.09
- MACD
- HCM 0.02
- DKL -0.21
- Stochastic Oscillator
- HCM 37.96
- DKL 28.53
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests
Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes Pipelines and Transportation; Pipelines and Transportation and Investments in Pipeline Joint Ventures. It generates maximum revenue from the Pipelines and Transportation segment. The pipelines and Transportation segment consist of pipelines, tanks, offloading facilities, trucks, and ancillary assets, which provide crude oil gathering and crude oil, intermediate and refined products transportation and storage services in support of Delek Holdings' refining operations in Tyler, Texas, El Dorado, Arkansas and Spring, Texas.